Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R WELTMAN

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Periodontology|May 12, 2000
Citric acid demineralization and subepithelial connective tissue graftsR G Caffesse, M De LaRosa, M Garza, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 19, 2025
Population Health Management for Improving Kidney Health OutcomesManisha Jhamb, Jane O Schell, Melanie R Weltman, et al.
International Journal of Dental Hygiene|December 24, 2015
Role of supportive maintenance therapy on implant survival: a university-based 17 years retrospective analysisI C Gay, D T Tran, R Weltman, et al.
Kidney Medicine|May 7, 2025
Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized TrialMelanie R Weltman, Zhuoheng Han, Linda-Marie U Lavenburg, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 19, 2025
Factors Associated With Initiation of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP TrialLinda-Marie U Lavenburg, Mitra Mosslemi, Zhuoheng Han, et al.
American Journal of Nephrology|June 17, 2025
Using Machine Learning to Predict Medication Therapy Problems among Patients with Chronic Kidney DiseaseAlaa A Alghwiri, Melanie R Weltman, Linda-Marie U Lavenburg, et al.
Chemosphere|February 28, 2012
Assessment of the environmental fate and effects of azilsartan, a selective antagonist of angiotensin II type 1R Weltman, C M J Brands, E Corral, et al.
Journal of General Internal Medicine|February 11, 2026
Primary Care Provider Perceptions of a Population Health Management Program to Improve Kidney Care: A Mixed Methods StudyMelanie R Weltman, Linda-Marie U Lavenburg, Balchandre Neilesh Kenkre, et al.
Contemporary Clinical Trials|June 22, 2023
Electronic health record based population health management to optimize care in CKD: Design of the Kidney Coordinated HeAlth Management Partnership (K-CHAMP) trialManisha Jhamb, Melanie R Weltman, Jonathan G Yabes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 6, 2025
Population Health Management Impact on Healthcare Utilization and Costs in CKD: Post Hoc Analysis of the Kidney Coordinated HeAlth Management Partnership TrialKangho Suh, Jane Kogan, Cindy Chan, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Periodontology|May 12, 2000
Citric acid demineralization and subepithelial connective tissue graftsR G Caffesse, M De LaRosa, M Garza, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 19, 2025
Population Health Management for Improving Kidney Health OutcomesManisha Jhamb, Jane O Schell, Melanie R Weltman, et al.
International Journal of Dental Hygiene|December 24, 2015
Role of supportive maintenance therapy on implant survival: a university-based 17 years retrospective analysisI C Gay, D T Tran, R Weltman, et al.
Kidney Medicine|May 7, 2025
Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized TrialMelanie R Weltman, Zhuoheng Han, Linda-Marie U Lavenburg, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 19, 2025
Factors Associated With Initiation of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonists in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the Kidney CHAMP TrialLinda-Marie U Lavenburg, Mitra Mosslemi, Zhuoheng Han, et al.
American Journal of Nephrology|June 17, 2025
Using Machine Learning to Predict Medication Therapy Problems among Patients with Chronic Kidney DiseaseAlaa A Alghwiri, Melanie R Weltman, Linda-Marie U Lavenburg, et al.
Chemosphere|February 28, 2012
Assessment of the environmental fate and effects of azilsartan, a selective antagonist of angiotensin II type 1R Weltman, C M J Brands, E Corral, et al.
Journal of General Internal Medicine|February 11, 2026
Primary Care Provider Perceptions of a Population Health Management Program to Improve Kidney Care: A Mixed Methods StudyMelanie R Weltman, Linda-Marie U Lavenburg, Balchandre Neilesh Kenkre, et al.
Contemporary Clinical Trials|June 22, 2023
Electronic health record based population health management to optimize care in CKD: Design of the Kidney Coordinated HeAlth Management Partnership (K-CHAMP) trialManisha Jhamb, Melanie R Weltman, Jonathan G Yabes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 6, 2025
Population Health Management Impact on Healthcare Utilization and Costs in CKD: Post Hoc Analysis of the Kidney Coordinated HeAlth Management Partnership TrialKangho Suh, Jane Kogan, Cindy Chan, et al.
Pageof 3